The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

Victor J. Dzau(Brigham and Women's Hospital), Michael A. Weber(SUNY Downstate Health Sciences University), Heribert Schunkert(University of Regensburg), Kenneth E. Bernstein(Cedars-Sinai Medical Center), Ahsan Husain(Emory University), Eva Lonn(McMaster University), Björn Dahlöf, Ton J. Rabelink(Leiden University Medical Center), David S. Celermajer(Children's Hospital at Westmead), Marcel Ruzicka(University of Ottawa), Willem J. Remme(AstraZeneca (United Kingdom)), Burkhard Hornig(Uppsala University), Douglas E. Vaughan(Brigham and Women's Hospital), John Deanfield(Great Ormond Street Hospital), Luís M. Ruilope(Brigham and Women's Hospital), Thomas Unger(Christian-Albrechts-Universität zu Kiel), Carl J. Pepine(Providence College), Javier Dı́ez(Universidad de Navarra), A Mimran(Hôpital Lapeyronie), Karl Swedberg(Sahlgrenska University Hospital), Roberto Ferrari(University of Ferrara), Colin I. Johnston(Baker Heart and Diabetes Institute), Jerome D. Cohen(Brigham and Women's Hospital), Helmut Drexler(Freie Universität Berlin), Lennart Hansson(Uppsala University), Thomas F. Lüscher(King's College - North Carolina), Harold L. Lazar(Boston Medical Center), John Mancini(Vancouver General Hospital), Wiek H. van Gilst(University Medical Center Groningen)
The American Journal of Cardiology
November 1, 2001
Cited by 260


Related Papers